Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

This was a hour ago

$BioXcel Therapeutics (BTAI.US)$ BioXcel Therapeutics Announces Update on NIDA-funded Trial of BXCL501 (Sublingual Dexmedetomidine) for Potential Treatment of Opioid Use Disorder (OUD)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
1
+0
4
Translate
Report
2406 Views
Comment
Sign in to post a comment
3612Followers
23Following
53KVisitors
Follow